357 related articles for article (PubMed ID: 2904115)
21. Somatostatin receptors on rat anterior pituitary membranes.
Enjalbert A; Tapia-Arancibia L; Rieutort M; Brazeau P; Kordon C; Epelbaum J
Endocrinology; 1982 May; 110(5):1634-40. PubMed ID: 6122557
[TBL] [Abstract][Full Text] [Related]
22. Somatostatin inhibits cAMP-dependent and cAMP-independent calcium influx in the clonal pituitary tumor cell line AtT-20 through the same receptor population.
Reisine T; Wang HL; Guild S
J Pharmacol Exp Ther; 1988 Apr; 245(1):225-31. PubMed ID: 2896236
[TBL] [Abstract][Full Text] [Related]
23. Identification of somatostatin receptors by covalent labeling with a novel photoreactive somatostatin analog.
Brown PJ; Lee AB; Norman MG; Presky DH; Schonbrunn A
J Biol Chem; 1990 Oct; 265(29):17995-8004. PubMed ID: 1976633
[TBL] [Abstract][Full Text] [Related]
24. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides.
Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T
Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350
[TBL] [Abstract][Full Text] [Related]
25. Distribution of somatostatin receptors in RINm5F insulinoma cells.
Sullivan SJ; Schonbrunn A
Endocrinology; 1988 Mar; 122(3):1137-45. PubMed ID: 2893729
[TBL] [Abstract][Full Text] [Related]
26. Binding and functional properties of the novel somatostatin analogue KE 108 at native mouse somatostatin receptors.
Cervia D; Langenegger D; Schuepbach E; Cammalleri M; Schoeffter P; Schmid HA; Bagnoli P; Hoyer D
Neuropharmacology; 2005 May; 48(6):881-93. PubMed ID: 15829258
[TBL] [Abstract][Full Text] [Related]
27. Somatostatin receptors in the nucleus accumbens selectively mediate the stimulatory effect of somatostatin on locomotor activity in rats.
Raynor K; Lucki I; Reisine T
J Pharmacol Exp Ther; 1993 Apr; 265(1):67-73. PubMed ID: 8097248
[TBL] [Abstract][Full Text] [Related]
28. Characterization of cloned somatostatin receptors SSTR4 and SSTR5.
Raynor K; O'Carroll AM; Kong H; Yasuda K; Mahan LC; Bell GI; Reisine T
Mol Pharmacol; 1993 Aug; 44(2):385-92. PubMed ID: 8102785
[TBL] [Abstract][Full Text] [Related]
29. Pertussis toxin blocks somatostatin inhibition of calcium mobilization and reduces the affinity of somatostatin receptors for agonists.
Reisine T; Guild S
J Pharmacol Exp Ther; 1985 Dec; 235(3):551-7. PubMed ID: 2867203
[TBL] [Abstract][Full Text] [Related]
30. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
Robben JH; Visser-Wisselaar HA; Rutteman GR; van Rijk PP; van Dongen AJ; Voorhout G; van den Ingh TS; Hofland LJ; Lamberts SW
J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
[TBL] [Abstract][Full Text] [Related]
31. Evidence for multiple protein constituents of the somatostatin receptor in pituitary tumor cells: affinity cross-linking and molecular characterization.
Murthy KK; Srikant CB; Patel YC
Endocrinology; 1989 Aug; 125(2):948-56. PubMed ID: 2568926
[TBL] [Abstract][Full Text] [Related]
32. Relationship between receptor binding and biopotency of somatostatin-14 and somatostatin-28 in mouse pituitary tumor cells.
Srikant CB; Heisler S
Endocrinology; 1985 Jul; 117(1):271-8. PubMed ID: 2861078
[TBL] [Abstract][Full Text] [Related]
33. Pertussis toxin modifies the characteristics of both the inhibitory GTP binding proteins and the somatostatin receptor in anterior pituitary tumor cells.
Mahy N; Woolkalis M; Thermos K; Carlson K; Manning D; Reisine T
J Pharmacol Exp Ther; 1988 Aug; 246(2):779-85. PubMed ID: 2900331
[TBL] [Abstract][Full Text] [Related]
34. Identification and characterisation of heterogeneous somatostatin binding sites in rat distal colonic mucosa.
McKeen ES; Feniuk W; Michel AD; Kidd EJ; Humphrey PP
Naunyn Schmiedebergs Arch Pharmacol; 1996 Nov; 354(5):543-9. PubMed ID: 8938650
[TBL] [Abstract][Full Text] [Related]
35. Differential agonist activity of somatostatin and L-362855 at human recombinant sst4 receptors.
Smalley KS; Feniuk W; Humphrey PP
Br J Pharmacol; 1998 Oct; 125(4):833-41. PubMed ID: 9831922
[TBL] [Abstract][Full Text] [Related]
36. Differential binding of somatostatin agonists to somatostatin receptors in brain and adenohypophysis.
Heiman ML; Murphy WA; Coy DH
Neuroendocrinology; 1987 Jun; 45(6):429-36. PubMed ID: 2886933
[TBL] [Abstract][Full Text] [Related]
37. Rapid sequestration and degradation of somatostatin analogues by isolated brain microvessels.
Pardridge WM; Eisenberg J; Yamada T
J Neurochem; 1985 Apr; 44(4):1178-84. PubMed ID: 2857772
[TBL] [Abstract][Full Text] [Related]
38. Development and use of a receptor antibody to characterize the interaction between somatostatin receptor subtype 1 and G proteins.
Gu YZ; Brown PJ; Loose-Mitchell DS; Stork PJ; Schonbrunn A
Mol Pharmacol; 1995 Dec; 48(6):1004-14. PubMed ID: 8847999
[TBL] [Abstract][Full Text] [Related]
39. Subtypes of brain somatostatin receptors couple to multiple cellular effector systems.
Raynor K; Wang HL; Dichter M; Reisine T
Mol Pharmacol; 1991 Aug; 40(2):248-53. PubMed ID: 1678852
[TBL] [Abstract][Full Text] [Related]
40. Somatostatin inhibits vasoactive intestinal peptide-stimulated cyclic adenosine monophosphate accumulation in GH pituitary cells.
Dorflinger LJ; Schonbrunn A
Endocrinology; 1983 Nov; 113(5):1541-50. PubMed ID: 6194974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
